Malignant Neoplasm of Brain (C71)

Name of the Condition

• Malignant neoplasm of brain
• Primary brain cancer

Summary

Malignant neoplasm of the brain refers to cancerous growths originating within the brain tissue. These tumors can disrupt normal brain function by invading or compressing surrounding structures, leading to a range of neurological symptoms. The condition is classified under ICD-10-CM code C71 and encompasses various subtypes based on tumor location and characteristics.

Causes

The exact cause of malignant brain tumors is often unknown. However, potential factors include genetic mutations, prior radiation exposure, and other unidentified environmental influences. Some cases may be linked to inherited genetic syndromes, though these are relatively rare.

Risk Factors

• Family history of brain tumors
• Genetic syndromes (e.g., neurofibromatosis, Li-Fraumeni syndrome)
• Previous exposure to ionizing radiation
• Increased age (more common in older adults)
• Certain immune system disorders

Symptoms

• Persistent headaches, often severe
• Seizures
• Cognitive or personality changes
• Nausea or vomiting
• Vision or speech difficulties
• Weakness or numbness in limbs
• Balance or coordination problems

Diagnosis

Diagnosis typically involves a combination of neurological examination, imaging tests such as MRI or CT scans to visualize the tumor, and biopsy to examine tumor tissue for malignancy. Additional tests may include blood work or lumbar puncture to assess cerebrospinal fluid.

Treatment Options

• Surgery: To remove as much of the tumor as safely possible, often the first-line treatment when feasible.
• Radiation therapy: To target and destroy remaining cancer cells, used post-surgery or when surgery isn’t feasible.
• Chemotherapy: Uses drugs to kill or slow tumor growth, may be administered orally or intravenously.
• Targeted therapy: Medications designed to target specific molecular characteristics of the tumor.
• Immunotherapy: Boosts the body’s immune system to fight cancer cells.

Prognosis and Follow-Up

Prognosis varies widely depending on tumor type, grade, location, and patient age. Regular follow-up with imaging and neurological assessments is essential to monitor for recurrence or progression. Treatment may be palliative in advanced cases to manage symptoms and improve quality of life.

Complications

• Increased intracranial pressure
• Neurological deficits (e.g., paralysis, vision loss)
• Seizure disorders
• Cognitive impairment
• Hormonal imbalances
• Infection or bleeding at the surgical site

Lifestyle & Prevention

• Avoid known carcinogens, such as tobacco and excessive alcohol.
• Protect against head injuries by using appropriate safety gear.
• Maintain a healthy lifestyle with regular exercise and a balanced diet.
• Limit exposure to ionizing radiation when possible.

When to Seek Professional Help

Seek immediate medical attention if experiencing:

• Sudden, severe headache
• New or worsening neurological symptoms (e.g., weakness, confusion)
• Seizures
• Persistent nausea or vomiting without obvious cause
• Changes in vision or speech

Tips for Medical Coders

When coding for malignant neoplasm of the brain (C71), ensure documentation specifies the tumor’s location and histological type when available. Note any associated conditions or complications that may require additional codes. Verify that the diagnosis aligns with clinical findings and imaging results to support accurate coding.